MedTrace Logo

Pathophysiology of Inflammation After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

NCT02741167 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2017-05-04

No results posted yet for this study

Summary

The purpose of this study is to assess the dynamics of inflammatory parameters in presence or absence of infectious complications after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.

Conditions

  • Peritoneal Cancer

Interventions

PROCEDURE

CRS and HIPEC

During CRS, all visible peritoneal tumors are removed. Consequently micrometastasis are removed with hyperthermic intraperitoneal chemotherapy

Sponsors & Collaborators

  • University of Zurich

    lead OTHER

Principal Investigators

  • Kuno Lehmann, Md. PhD · Dr. Kuno Lehmann, Division of Visceral Surgery and Transplantation, University Hospital Zurich, Ramistrasse 100, 8091 Zurich, Switzerland

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02741167 on ClinicalTrials.gov